Skip to main content

Neurotransmitters, signal transduction and second‐messengers in Alzheimer's disease

Buy Article:

$51.00 plus tax (Refund Policy)


It has long been assumed that widespread changes in postsynaptic neurotransmitter receptor function are not a feature of the disrupted neurotransmission seen in the brains with Alzheimer's disease (AD). However, recent evidence from postmortem brain and fibroblast studies suggests that both the neurotransmitter receptor/G‐protein‐modulated adenylyl cyclase and the phosphatidylinositol hydrolysis signal transduction cascades are disrupted in AD. Such disruptions may severely limit the functional integrity of key receptor types and undermine pharmacological attempts to ameliorate disease symptomatology through neurotransmitter replacement strategies. The involvement of some signalling mechanisms in the regulation of β‐amyloid precursor protein metabolism suggests also that disrupted signal transduction may exacerbate AD pathology.

Document Type: Original Article


Affiliations: 1: Alzheimer's Disease Research Centre, Karolinska Institute, Stockholm 2: Department of Pharmacology, Umeå University, Sweden 3: Department of Biochemistry, University College, Lee Maltings, Cork, Ireland

Publication date: April 1, 1996


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more